Universidad de Cantabria-ko ikertzaileekin lankidetzan egindako argitalpenak (12)

2023

  1. Changes in PRC1 activity during interphase modulate lineage transition in pluripotent cells

    Nature communications, Vol. 14, Núm. 1, pp. 180

2022

  1. Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

    Blood Cancer Journal

2021

  1. Synthetase of the methyl donor S-adenosylmethionine from nitrogen-fixing α-rhizobia can bind functionally diverse RNA species

    RNA Biology, Vol. 18, Núm. 8, pp. 1111-1123

2019

  1. Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions

    Haematologica, Vol. 104, Núm. 6, pp. 1189-1201

2011

  1. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis

    Atherosclerosis, Vol. 216, Núm. 1, pp. 125-130

2010

  1. Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 1, pp. 68-72

  2. Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 5, pp. 695-701

  3. Reply

    Clinical and Experimental Rheumatology

2009

  1. Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovasular events in rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 1, pp. 116-119

  2. Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 27, Núm. 6, pp. 964-970

2007

  1. Assessing the relevance of higher education courses

    Evaluation and Program Planning, Vol. 30, Núm. 2, pp. 149-160

2005

  1. Blockade of epidermal growth factor receptors chemosensitizes breast cancer cells through up-regulation of Bnip3L

    Cancer Research, Vol. 65, Núm. 18, pp. 8151-8157